Charles Joseph Magolske
Algemeen Directeur bij Artin Bioscience, Inc.
Actieve functies van Charles Joseph Magolske
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Artin Bioscience, Inc.
Artin Bioscience, Inc. BiotechnologyHealth Technology Artin Bioscience, Inc. is an American US-based company that is pioneering precision therapeutics to treat serious diseases triggered by intestinal inflammation. The company is creating a new class of transformative precision therapeutics that target and block the root causes of diverse diseases. Artin Bioscience is backed by highly respected investors and governed by a prestigious board of directors with broad industry experience. The company uses multi-modality approaches to correct intestinal dysbiosis by neutralizing the core triggers of the inflammatory process. Artin Bioscience's proprietary drug discovery platform identifies and characterizes microbial drivers of disease within precise patient subsets in certain cancers and gastrointestinal, metabolic, autoimmune, and neurodegenerative diseases. The company's world-class biobanking program collects proprietary samples and clinical data from patients and healthy controls to enable critical research into disease mechanisms and aid the development of potential treatments. | Directeur/Bestuurslid | - | - |
Algemeen Directeur | - | - |
Loopbaan van Charles Joseph Magolske
Eerdere bekende functies van Charles Joseph Magolske
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
TITAGARH RAIL SYSTEMS LIMITED | Directeur/Bestuurslid | 14-02-2011 | 24-12-2012 |
Independent Dir/Board Member | 04-02-2011 | 24-12-2012 | |
FREIGHTCAR AMERICA, INC. | Corporate Officer/Principal | 15-12-2009 | 15-12-2009 |
TRINITY INDUSTRIES, INC. | Verkoop & Marketing | 01-01-2001 | 01-01-2002 |
OROCO RESOURCE CORP. | Corporate Officer/Principal | - | - |
AUGUSTA RESOURCE CORP. | Verkoop & Marketing | 16-02-2011 | - |
ARIZONA MINING INC | Corporate Officer/Principal | 21-12-2010 | - |
Opleiding van Charles Joseph Magolske
University of Virginia Darden School of Business | Masters Business Admin |
Statistieken
Internationaal
Verenigde Staten | 5 |
Canada | 4 |
India | 2 |
Operationeel
Corporate Officer/Principal | 3 |
Sales & Marketing | 2 |
Director/Board Member | 2 |
Sectoraal
Producer Manufacturing | 4 |
Non-Energy Minerals | 4 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 4 |
---|---|
TRINITY INDUSTRIES, INC. | Producer Manufacturing |
FREIGHTCAR AMERICA, INC. | Producer Manufacturing |
OROCO RESOURCE CORP. | Non-Energy Minerals |
TITAGARH RAIL SYSTEMS LIMITED | Producer Manufacturing |
Bedrijven in privébezit | 3 |
---|---|
HudBay Arizona Corp.
HudBay Arizona Corp. Other Metals/MineralsNon-Energy Minerals HudBay Arizona Corp. engaged in the exploration and development of mineral properties. The company was founded on January 14, 1937 and is headquartered in Vancouver, Canada. | Non-Energy Minerals |
Arizona Mining, Inc.
Arizona Mining, Inc. Precious MetalsNon-Energy Minerals Arizona Mining, Inc. engaged in the exploration and development of silver, zinc and lead. The firm focuses on the Hermosa Project, which is located in Santa Cruz County, Arizona. Arizona Mining was founded on January 20, 1975 and was headquartered in Vancouver, Canada. | Non-Energy Minerals |
Artin Bioscience, Inc.
Artin Bioscience, Inc. BiotechnologyHealth Technology Artin Bioscience, Inc. is an American US-based company that is pioneering precision therapeutics to treat serious diseases triggered by intestinal inflammation. The company is creating a new class of transformative precision therapeutics that target and block the root causes of diverse diseases. Artin Bioscience is backed by highly respected investors and governed by a prestigious board of directors with broad industry experience. The company uses multi-modality approaches to correct intestinal dysbiosis by neutralizing the core triggers of the inflammatory process. Artin Bioscience's proprietary drug discovery platform identifies and characterizes microbial drivers of disease within precise patient subsets in certain cancers and gastrointestinal, metabolic, autoimmune, and neurodegenerative diseases. The company's world-class biobanking program collects proprietary samples and clinical data from patients and healthy controls to enable critical research into disease mechanisms and aid the development of potential treatments. | Health Technology |